Evidence map›Paper›PMID 27613190›Full record

ReviewDrug delivery and translational research2016

Human corneal cell culture models for drug toxicity studies.

Seppo Rönkkö, Kati-Sisko Vellonen, Kristiina Järvinen, Elisa Toropainen, Arto Urtti

Abstract readReview
In one paragraph

Review in Drug delivery and translational research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed.

  1. Review
  2. Article
  3. Biogenic silver nanoparticles from chamomile incorporated in hydrogels for high transparent non-infectiveness contact lenses.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2025
    Article
  4. Article
  5. Article
  6. PLL-g-PEG Polymer Inhibits Antibody-Drug Conjugate Uptake into Human Corneal Epithelial CellsJournal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. An Open-Source Add-On EVOMMicromachines · 2021
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Microphysiological Systems: Design, Fabrication, and Applications.ACS biomaterials science & engineering · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Seppo RönkköSchool of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O.Box 1627, 70211, Kuopio, Finland.
Kati-Sisko VellonenSchool of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O.Box 1627, 70211, Kuopio, Finland.
Kristiina JärvinenSchool of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O.Box 1627, 70211, Kuopio, Finland.
Elisa ToropainenSchool of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O.Box 1627, 70211, Kuopio, Finland.
Arto UrttiSchool of Pharmacy, Faculty of Health Sciences, University of Eastern Finland, P.O.Box 1627, 70211, Kuopio, Finland. arto.urtti@uef.fi.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In vivo toxicity and absorption studies of topical ocular drugs are problematic, because these studies involve invasive tissue sampling and toxic effects in animal models. Therefore, different human corneal models ranging from simple monolayer cultures to three-dimensional models have been developed for toxicological prediction with in vitro models. Each system has its own set of advantages and disadvantages. Use of non-corneal cells, inadequate characterization of gene-expression profiles, and accumulation of genomic aberrations in human corneal models are typical drawbacks that decrease their reliability and predictive power. In the future, further improvements are needed for verifying comparable expression profiles and cellular properties of human corneal models with their in vivo counterparts. A rapidly expanding stem cell technology combined with tissue engineering may give future opportunities to develop new tools in drug toxicity studies. One approach may be the production of artificial miniature corneas. In addition, there is also a need to use large-scale profiling approaches such as genomics, transcriptomics, proteomics, and metabolomics for understanding of the ocular toxicity.

Indexed as

Drug-Related Side Effects and Adverse ReactionsCell Culture TechniquesCorneaEpithelial CellsHumansToxicity TestsADME predictionCorneal cell cultureIn vitro modelOcular bioavailabilityOcular toxicity

Identifiers

PMID27613190
PMCPMC5097077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.